Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Plos One|November 24, 2011
A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapyAna C Xavier, Holly Edwards, Alan A Dombkowski, et al.
Pediatric Blood & Cancer|May 28, 2024
COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignanciesBlake Foxworthy, Chen Dai, Elizabeth C Davis, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|November 20, 2020
Genomic imbalances in craniofacial microsomiaSamira Spineli-Silva, Ilária C Sgardioli, Ana P Dos Santos, et al.
Journal of Thrombosis and Haemostasis : JTH|March 2, 2021
Pediatric May-Thurner Syndrome-Systematic review and individual patient data meta-analysisLaura Avila, Noelle Cullinan, Michael White, et al.
Blood|October 29, 2025
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predispositionLeila Ronceray, Minke H W Huibers, Katrin Reutter, et al.
Birth Defects Research|September 27, 2017
CranFlow: An Application for Record-Taking and Management Through the Brazilian Database on Craniofacial AnomaliesRoberta M Volpe-Aquino, Isabella L Monlleó, Elaine Lustosa-Mendes, et al.
British Journal of Haematology|December 22, 2017
R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysisNirav N Shah, Aniko Szabo, Scott F Huntington, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2020
Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyKimberly Davies, Matthew Barth, Saro Armenian, et al.
Leukemia & Lymphoma|October 3, 2018
Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of originTalha Badar, Mehdi Hamadani, Veronika Bachanova, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 9, 2022
Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in OncologyMatthew Barth, Ana C Xavier, Saro Armenian, et al.
Pageof 5